Search

Your search keyword '"Khalife, Mohamad"' showing total 270 results
Start Over Author "Khalife, Mohamad"
270 results on '"Khalife, Mohamad"'

4. Features of Mild-to-Moderate COVID-19 Patients With Dysphonia

Author

Lechien, Jerome R., Chiesa-Estomba, Carlos M., Cabaraux, Pierre, Mat, Quentin, Huet, Kathy, Harmegnies, Bernard, Horoi, Mihaela, Le Bon, Serge Daniel, Rodriguez, Alexandra, Dequanter, Didier, Hans, Stéphane, Crevier-Buchman, Lise, Hochet, Baptiste, Distinguin, Lea, Chekkoury-Idrissi, Younes, Circiu, Marta, El Afia, Fahd, Barillari, Maria Rosaria, Cammaroto, Giovanni, Fakhry, Nicolas, Michel, Justin, Radulesco, Thomas, Martiny, Delphine, Lavigne, Philippe, Jouffe, Lionel, Descamps, Géraldine, Journe, Fabrice, Trecca, Eleonora M.C., Hsieh, Julien, Delgado, Irene Lopez, Calvo-Henriquez, Christian, Vergez, Sebastien, Khalife, Mohamad, Molteni, Gabriele, Mannelli, Giuditta, Cantarella, Giovanna, Tucciarone, Manuel, Souchay, Christel, Leich, Pierre, Ayad, Tareck, and Saussez, Sven

Published
2022
Full Text
View/download PDF

11. Validity and Reliability of the French Short Version of the Questionnaire of Olfactory Disorders-Negative Statements (sQOD-NS).

Author

Leclercq, Céline, Chiesa-Estomba, Carlos M., Horoi, Mihaela, Le Bon, Serge D., Hans, Stephane, Distinguin, Lea, Chekkoury-Idrissi, Younes, Circiu, Marta P., Khalife, Mohamad, Saussez, Sven, and Lechien, Jérôme R.

Subjects
EXPERIMENTAL design, STATISTICS, RESEARCH evaluation, STATISTICAL reliability, RESEARCH methodology, RESEARCH methodology evaluation, VISUAL analog scale, MANN Whitney U Test, SEVERITY of illness index, CRONBACH'S alpha, QUESTIONNAIRES, QUALITY of life, SMELL disorders, DESCRIPTIVE statistics, DATA analysis software, DATA analysis, STATISTICAL correlation, FRENCH people
Abstract

Objective: To develop a French Short Version of the Questionnaire of Olfactory Disorders-Negative Statements (Fr-sQOD) to assess the quality of life impairments of patients with olfactory dysfunction (OD). Methods: Patients with OD and controls were enrolled from 2 academic centers. Individuals completed the Fr-sQOD, an OD visual analog scale severity, and the French version of the sinonasal outcome tool-22 (SNOT-22). Cronbach α was used to measure the internal consistency of Fr-sQOD. The reliability and the external validity of Fr-sQOD were assessed through a test–retest approach and by correlating Fr-sQOD with SNOT-22 scores, respectively. The external validity was assessed by correlation analysis between Fr-sQOD and the result of an assessment of the severity of OD on a visual analog scale. Results: Eighty patients completed the evaluations. The internal consistency was adequate (Cronbach α.96), and the test–retest reliability was high in the entire cohort (rs = 0.877, P <.001). The correlation between Fr-sQOD total scores and the severity of OD was moderate but significant (rs = −0.431; P =.001) supporting an acceptable external validity. Patients with OD had a significantly higher score of Fr-sQOD than healthy individuals (P <.001), indicating a high internal validity. Conclusion: The Fr-sQOD is a reliable and valid self-administered tool in the evaluation of the impact of OD on quality of life of French-speaking patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

33. Validity and Reliability of the French Short Version of the Questionnaire of Olfactory Disorders-Negative Statements (sQOD-NS)

Author

Leclercq, Céline, primary, Chiesa-Estomba, Carlos M., additional, Horoi, Mihaela, additional, Le Bon, Serge D., additional, Hans, Stephane, additional, Distinguin, Lea, additional, Chekkoury-Idrissi, Younes, additional, Circiu, Marta P., additional, Khalife, Mohamad, additional, Saussez, Sven, additional, and Lechien, Jérôme R., additional

Published
2021
Full Text
View/download PDF

34. Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction

Author

Saussez, Sven, primary, Sharma, Shilpee, additional, Thiriard, Anaïs, additional, Olislagers, Véronique, additional, Vu Duc, Inès, additional, Le Bon, Serge‐D., additional, Khalife, Mohamad, additional, Hans, Stephane, additional, De Riu, Giacomo, additional, Hopkins, Claire, additional, Lechien, Jerome R., additional, Vaira, Luigi A., additional, and Marchant, Arnaud, additional

Published
2021
Full Text
View/download PDF

35. Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study

Author

Saussez, Sven, primary, Vaira, Luigi, additional, Chiesa-Estomba, Carlos, additional, Le Bon, Serge, additional, Horoi, Mihaela, additional, Deiana, Giovanna, additional, Petrocelli, Marzia, additional, Boelpaep, Philippe, additional, Salzano, Giovanni, additional, Khalife, Mohamad, additional, Hans, Stephane, additional, De Riu, Giacomo, additional, Hopkins, Claire, additional, and Lechien, Jerome, additional

Published
2021
Full Text
View/download PDF

36. Comparison Between Liver Stiffness Measurement by Fibroscan and Splenic Volume Index as NonInvasive Tools for the Early Detection of Oxaliplatin-induced Hepatotoxicity

Author

Bouferraa, Youssef, primary, Haibe, Yolla, additional, Jabra, Elio, additional, Charafeddine, Maya, additional, Kreidieh, Malek, additional, Raad, Randa, additional, Temraz, Sally, additional, Mukherji, Deborah, additional, Ershaid, Firas, additional, Muallem, Nadim, additional, Faraj, Walid, additional, Khalife, Mohamad, additional, Eid, Rania A., additional, and Shamseddine, Ali, additional

Published
2021
Full Text
View/download PDF

38. Ratio Between Positive Lymph Nodes and Total Excised Axillary Lymph Nodes as an Independent Prognostic Factor for Overall Survival in Patients with Nonmetastatic Lymph Node-Positive Breast Cancer

Author

Hatoum, Hassan A., Jamali, Faek R., El-Saghir, Nagi S., Musallam, Khaled M., Seoud, Muhieddine, Dimassi, Hani, Abbas, Jaber, Khalife, Mohamad, Boulos, Fouad I., Tawil, Ayman N., Geara, Fadi B., Salem, Ziad, Shamseddine, Achraf A., Al-Feghali, Karine, and Shamseddine, Ali I.

Published
2010
Full Text
View/download PDF

39. Ratio Between Positive Lymph Nodes and Total Excised Axillary Lymph Nodes as an Independent Prognostic Factor for Overall Survival in Patients with Nonmetastatic Lymph Node-Positive Breast Cancer

Author

Hatoum, Hassan A., Jamali, Faek R., El-Saghir, Nagi S., Musallam, Khaled M., Seoud, Muhieddine, Dimassi, Hani, Abbas, Jaber, Khalife, Mohamad, Boulos, Fouad I., Tawil, Ayman N., Geara, Fadi B., Salem, Ziad, Shamseddine, Achraf A., Al-Feghali, Karine, and Shamseddine, Ali I.

Published
2009
Full Text
View/download PDF

40. Psychophysical Evaluation of the Olfactory Function: European Multicenter Study on 774 COVID-19 Patients

Author

Vaira, Luigi Angelo, primary, Lechien, Jerome R., additional, Khalife, Mohamad, additional, Petrocelli, Marzia, additional, Hans, Stephane, additional, Distinguin, Lea, additional, Salzano, Giovanni, additional, Cucurullo, Marco, additional, Doneddu, Piero, additional, Salzano, Francesco Antonio, additional, Biglioli, Federico, additional, Journe, Fabrice, additional, Piana, Andrea Fausto, additional, De Riu, Giacomo, additional, and Saussez, Sven, additional

Published
2021
Full Text
View/download PDF

43. Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019

Author

Lechien, Jerome R., Chiesa‐Estomba, Carlos M., Place, Sammy, Van Laethem, Yves, Cabaraux, Pierre, Mat, Quentin, Huet, Kathy, Plzak, Jan, Horoi, Mihaela, Hans, Stéphane, Rosaria Barillari, Maria, Cammaroto, Giovanni, Fakhry, Nicolas, Martiny, Delphine, Ayad, Tareck, Jouffe, Lionel, Hopkins, Claire, Saussez, Sven, Blecic, Serge, De Siati, Daniele R., Leich, Pierre, Souchay, Christel, Rossi, Camelia, Journe, Fabrice, Hsieh, Julien, Ris, Laurence, El Afia, Fahd, Harmegnies, Bernard, Distinguin, Lea, Chekkoury‐Idrissi, Younes, Circiu, Marta, Lavigne, Philippe, Lopez Delgado, Irene, Calvo‐Henriquez, Christian, Falanga, Chiara, Coppee, Frederique, Le Bon, Serge Daniel, Rodriguez, Alexandra, Dequanter, Didier, Cornelis, Jean‐Philippe, Vergez, Sebastien, Koenen, Lukas, Giuditta, Mannelli, Molteni, Gabriele, Tucciarone, Manuel, Radulesco, Thomas, Khalife, Mohamad, Fourneau, Anne‐Francoise, Cherifi, Soraya, Manto, Mario, Michel, Justin, Mannelli, Giuditta, Cantarella, Giovanna, Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Assistance Publique - Hôpitaux de Marseille (APHM), Laboratoire Parole et Langage (LPL), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), We would like to thank Bayesia (BayesiaLab?, Chang?, France) for the Network Analysis, Jean-Louis Vincent and Michel Van Haeverbeek for the review of the paper or their useful comments, the heads of the Hospitals, which have been involved in the study, for their help in the rapid conduction of the study and the agreement of ethics committees, the European Press/Media (i.e. Le Monde, La Libre, Le Soir, MediQuality, MedScape, and Le Specialiste) for their help in the spread of the information about the study, and FRMH & UMONS for the grant and the support., Lechien, J. R., Chiesa-Estomba, C. M., Place, S., Van Laethem, Y., Cabaraux, P., Mat, Q., Huet, K., Plzak, J., Horoi, M., Hans, S., Barillari, M. R., Cammaroto, G., Fakhry, N., Martiny, D., Ayad, T., Jouffe, L., Hopkins, C., Saussez, S., Blecic, S., De Siati, D. R., Leich, P., Souchay, C., Rossi, C., Journe, F., Hsieh, J., Ris, L., El Afia, F., Harmegnies, B., Distinguin, L., Chekkoury-Idrissi, Y., Circiu, M., Lavigne, P., Lopez Delgado, I., Calvo-Henriquez, C., Falanga, C., Coppee, F., Le Bon, S. D., Rodriguez, A., Dequanter, D., Cornelis, J. -P., Vergez, S., Koenen, L., Giuditta, M., Molteni, G., Tucciarone, M., Radulesco, T., Khalife, M., Fourneau, A. -F., Cherifi, S., Manto, M., Michel, J., Mannelli, G., and Cantarella, G.

Subjects
0301 basic medicine, myalgia, Male, medicine, Original, [SDV]Life Sciences [q-bio], coronavirus, symptoms, Disease, epidemiological, 030204 cardiovascular system & hematology, patients, clinical, Olfaction Disorders, Taste Disorders, 0302 clinical medicine, Epidemiology, Sore throat, Prevalence, Nose, Age Factors, Headache, Middle Aged, 3. Good health, Europe, medicine.anatomical_structure, COVID-19, Female, patient, medicine.symptom, Symptom Assessment, Coronavirus Infections, Sex characteristics, Adult, medicine.medical_specialty, Pneumonia, Viral, 03 medical and health sciences, Betacoronavirus, Sex Factors, Throat, Internal medicine, Internal Medicine, Humans, Pandemics, covid‐19, rhinorrhea, business.industry, SARS-CoV-2, Bayes Theorem, Myalgia, coronaviru, 030104 developmental biology, business
Abstract

International audience; Background: The clinical presentation of European patients with mild-to-moderate COVID-19 infection is still unknown. Objective: To study the clinical presentation of COVID-19 in Europe. Methods: Patients with positive diagnosis of COVID-19 were recruited from 18 European hospitals. Epidemiological and clinical data were obtained through a standardized questionnaire. Bayesian analysis was used for analysing the relationship between outcomes. Results: A total of 1,420 patients completed the study (962 females, 30.7% of healthcare workers). The mean age of patients was 39.17 ± 12.09 years. The most common symptoms were headache (70.3%), loss of smell (70.2%), nasal obstruction (67.8%), cough (63.2%), asthenia (63.3%), myalgia (62.5%), rhinorrhea (60.1%), gustatory dysfunction (54.2%) and sore throat (52.9%). Fever was reported by 45.4%. The mean duration of COVID-19 symptoms of mild-to-moderate cured patients was 11.5 ± 5.7 days. The prevalence of symptoms significantly varied according to age and sex. Young patients more frequently had ear, nose and throat complaints, whereas elderly individuals often presented fever, fatigue and loss of appetite. Loss of smell, headache, nasal obstruction and fatigue were more prevalent in female patients. The loss of smell was a key symptom of mild-to-moderate COVID-19 patients and was not associated with nasal obstruction and rhinorrhea. Loss of smell persisted at least 7 days after the disease in 37.5% of cured patients. Conclusion: The clinical presentation of mild-to-moderate COVID-19 substantially varies according to the age and the sex characteristics of patients. Olfactory dysfunction seems to be an important underestimated symptom of mild-to-moderate COVID-19 that needs to be recognized as such by the WHO.

Published
2020
Full Text
View/download PDF

44. Objective Olfactory Evaluation of Self-reported Olfactory Dysfunction in a Case Series of 86 COVID-19 Patients

Author

Cabaraux, Pierre, Lechien, Jerome R., saussez, sven, Chiesa-Estomba, Carlos M, Khalife, Mohamad, Hans, Stephane, Martiny, Delphine, Journe, Fabrice, Henriquez, Christian Calvo, and Sowerby, Leigh

Abstract

Objective: To investigate olfactory dysfunction in patients with mild COVID-19 through patient-reported outcome questionnaires and objective psychophysical testing. Methods: Adult patients with COVID-19 and self-reported sudden-onset olfactory dysfunction were recruited through a public call for participation from the University of Mons. Demographic data, pathologic conditions, general and otolaryngological symptoms were collected, and general nasal complaints were evaluated with the sino-nasal outcome-22 (SNOT-22). Subjective olfactory and gustatory status was evaluated with the National Health and Nutrition Examination Survey (NHNES) and the short version of the Questionnaire of Olfactory Disorders-Negative Statements. Objective olfactory status was evaluated using an objective psychophysical test (Identification Sniffin Stick test). Results : 86 patients completed the study. The mean age was 42 + or - 12 years. The most common symptoms were fatigue (75%), headache (63%), nasal obstruction (58%), dysgeusia (51%), postnasal drip (49%), cough (49%) and myalgia (46%). On NHNES, total loss of taste and smell were reported by 51% and 74% of patients, respectively. 65% of patients reported a total loss of smell, while the remainder reported a partial loss. Objective olfactory testing found 41 anosmic (48%), 12 hyposmics (14%), and 33 normosmics (38%) patients. There was no correlation between the objective test results and subjective reports of nasal obstruction or postnasal drip, these complaints were absent in 69% of anosmic patients. Conclusion : A significant proportion of patients reporting olfactory dysfunction related to COVID-19 infection do not have olfactory dysfunction on objective testing. Furthermore, a majority of those with measured olfactory dysfunction did not have corresponding nasal obstruction.

Published
2020
Full Text
View/download PDF

49. Objective Olfactory Findings in Hospitalized Severe COVID-19 Patients

Author

Lechien, Jerome R., primary, Ducarme, Morgane, additional, Place, Sammy, additional, Chiesa-Estomba, Carlos M., additional, Khalife, Mohamad, additional, De Riu, Giacomo, additional, Vaira, Luigi Angelo, additional, de Terwangne, Christophe, additional, Machayekhi, Shahram, additional, Marchant, Arnaud, additional, Journe, Fabrice, additional, and Saussez, Sven, additional

Published
2020
Full Text
View/download PDF

50. Psychophysical Olfactory Tests and Detection of COVID-19 in Patients With Sudden Onset Olfactory Dysfunction: A Prospective Study

Author

Lechien, Jerome R., primary, Cabaraux, Pierre, additional, Chiesa-Estomba, Carlos M., additional, Khalife, Mohamad, additional, Plzak, Jan, additional, Hans, Stéphane, additional, Martiny, Delphine, additional, Calvo-Henriquez, Christian, additional, Barillari, Maria R., additional, Hopkins, Claire, additional, and Saussez, Sven, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results